Demonstration of Neutralizing Mucosal IgA Response to Intranasal HIV-1 env DNA Vaccines With or Without the V3 Glycosylation Site

Author： Rowcliffe Eric Bolmstedt Anders Biller Marlene Wahren Britta Olofsson Sigvard Hinkula Jorma

Publisher： Informa Healthcare

ISSN： 0036-5548

Source： Scandinavian Journal of Infectious Diseases, Vol.36, Iss.5, 2004-05, pp. : 360-364

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Presence of HIV-1 Neutralizing IgA Antibodies in Primary HIV-1 Infected Patients

By Söderlund Johan Hirbod Taha Goh Li-ean Andersson Jan Broliden Kristina

Scandinavian Journal of Infectious Diseases, Vol. 36, Iss. 9, 2004-09 ,pp. : 663-669

Informa Healthcare

Access to resources Recommend Favorite

Immunogenicity of Neutralizing Epitopes on Multiple–Epitope Vaccines against HIV–1

International Archives of Allergy and Immunology, Vol. 121, Iss. 1, 2000-02 ,pp. : 80-84

Karger

Access to resources Recommend Favorite

Transmission of IgA and IgG Monoclonal Antibodies to Mucosal Fluids following Intranasal or Parenteral Delivery

International Archives of Allergy and Immunology, Vol. 122, Iss. 2, 2000-06 ,pp. : 143-150

Karger

Access to resources Recommend Favorite

Induction of High Levels of Antibodies Recognizing the Neutralizing Epitope ELDKWA and the D- or K-Position-Mutated Epitopes by Candidate Epitope Vaccines against HIV-1

International Archives of Allergy and Immunology, Vol. 122, Iss. 4, 2000-09 ,pp. : 287-292

Karger

Access to resources Recommend Favorite

Impact of Codon Usage Modification on T Cell Immunogenicity and Longevity of HIV-1 Gag-Specific DNA Vaccines

Intervirology, Vol. 45, Iss. 4-6, 2003-01 ,pp. : 275-286

Karger

Access to resources Recommend Favorite